ERK2 Kit CLIA
Aperçu rapide pour ERK2 Kit CLIA (ABIN6216849)
Antigène
Voir toutes ERK2 (MAPK1) Kits CLIAReactivité
Méthode de détection
Type de méthode
Gamme de detection
Application
Type d'échantillon
-
-
Seuil minimal de détection
- 0.156 ng/mL
-
Analytical Method
- Quantitative
-
Sensibilité
- < 0.063 ng/mL
-
-
-
-
Plaque
- Pre-coated
-
Restrictions
- For Research Use only
-
-
-
Stock
- 4 °C
-
Stockage commentaire
- Shipped at 4°C. Upon receipt, store the kit according to the storage instruction in the kit's manual.The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
-
Date de péremption
- 6 months
-
-
- ERK2 (MAPK1) (Mitogen-Activated Protein Kinase 1 (MAPK1))
-
Autre désignation
- Extracellular Signal Regulated Kinase 2 (ERK2)
-
Pathways
- Signalisation MAPK, Signalisation RTK, Apoptose, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, Response to Growth Hormone Stimulus, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Monocarboxylic Acid Catabolic Process, Autophagy, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGFR1 Specific Signals, BCR Signaling, S100 Proteins
Antigène Voir toutes ERK2 (MAPK1) Kits CLIA
-